Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 6
2013 2
2014 5
2015 3
2016 3
2017 2
2018 1
2019 5
2020 5
2021 5
2022 2
2023 4
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for laurin lp[au]
Your search for Maurin LP[au] retrieved no results
CureGN-Diabetes Study: Rationale, Design, and Methods of a Prospective Observational Study of Glomerular Disease Patients with Diabetes.
Mottl AK, Bomback AS, Mariani LH, Coppock G, Jennette JC, Almaani S, Gipson DS, Kelley S, Kidd J, Laurin LP, Mucha K, Oliverio A, Palmer M, Rizk D, Sanghani N, Stokes MB, Susztak K, Wadhwani S, Nast CC. Mottl AK, et al. Among authors: laurin lp. Glomerular Dis. 2023 Jun 26;3(1):155-164. doi: 10.1159/000531679. eCollection 2023 Jan-Dec. Glomerular Dis. 2023. PMID: 37901700 Free PMC article.
Hemodialysis effects on phenytoin pharmacokinetics.
Bezzaoucha S, Merghoub A, Lamarche C, Pichette V, Lafrance JP, Laurin LP, Vallée M, Robitaille R, Leblanc M, Bell R. Bezzaoucha S, et al. Among authors: laurin lp. Eur J Clin Pharmacol. 2014 Apr;70(4):499-500. doi: 10.1007/s00228-013-1628-z. Epub 2014 Jan 4. Eur J Clin Pharmacol. 2014. PMID: 24390629 No abstract available.
CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease.
Mariani LH, Bomback AS, Canetta PA, Flessner MF, Helmuth M, Hladunewich MA, Hogan JJ, Kiryluk K, Nachman PH, Nast CC, Rheault MN, Rizk DV, Trachtman H, Wenderfer SE, Bowers C, Hill-Callahan P, Marasa M, Poulton CJ, Revell A, Vento S, Barisoni L, Cattran D, D'Agati V, Jennette JC, Klein JB, Laurin LP, Twombley K, Falk RJ, Gharavi AG, Gillespie BW, Gipson DS, Greenbaum LA, Holzman LB, Kretzler M, Robinson B, Smoyer WE, Guay-Woodford LM; CureGN Consortium. Mariani LH, et al. Among authors: laurin lp. Am J Kidney Dis. 2019 Feb;73(2):218-229. doi: 10.1053/j.ajkd.2018.07.020. Epub 2018 Nov 9. Am J Kidney Dis. 2019. PMID: 30420158 Free PMC article.
Proteinuria as an Endpoint in Clinical Trials of Focal Segmental Glomerulosclerosis.
Mariani LH, Trachtman H, Thompson A, Gillespie BS, Denburg M, Diva U, Geetha D, Greasley PJ, Hladunewich MA, Huizinga RB, Inrig JK, Komers R, Laurin LP, Little DJ, Nachman PH, Smith KA, Walsh L, Gibson KL. Mariani LH, et al. Among authors: laurin lp. Am J Kidney Dis. 2024 Oct 23:S0272-6386(24)01038-2. doi: 10.1053/j.ajkd.2024.08.011. Online ahead of print. Am J Kidney Dis. 2024. PMID: 39455047
43 results